Bizengri Injection
Product Images NDC 71837-1000

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bizengri (NDC 71837-1000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Partner Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Biz00 0001 01)

Figure (Biz00 0001 01)
The image shows a vial of BIZENGRI containing Zenocutuzumab injection. The vial's label indicates a concentration of 20 mg/mL. This product is intended for intravenous use and is manufactured by Partner Therapeutics, Inc.*
FDA Label Image

Figure (Biz00 0001 02)

Figure (Biz00 0001 02)
BIZENGRI injection vial label showing the product name BIZENGRI and generic name Zenocutuzumab. The label indicates the intravenous injection dosage form with a strength of 20 mg/mL. The vial is a small clear glass container with a white cap and a white label bearing black and green text. The labeler is Partner Therapeutics, Inc.*
FDA Label Image

Principal Display Panel – 750 mg Carton Label (Biz00 0001 03)

Principal Display Panel – 750 mg Carton Label (Biz00 0001 03)
Carton packaging label for Bizengri (zenocutuzumab-zbco) injection 750 mg, with a concentration of 375 mg/18.75 mL (20 mg/mL) per vial. The label indicates the product is for intravenous infusion after dilution. It includes handling and storage instructions, dosage directions referring to prescribing information, and manufacturer details for Partner Therapeutics, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.